| Code | 8738D | ||||||||||
| MA number | 44/0260/21-S | ||||||||||
| Product Form: | cps dur 60x100 mg (blis.PVC/PVDC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | AS GRINDEKS, Latvia | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 60 | ||||||||||
| Container: | blister PVC/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 10.11.2021 |
| Validity: | 10.11.2026 |
| MA renewed: | Renewal application submitted |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Imatinib Grindeks 100 mg tvrdé kapsuly_08.2023.pdf
|
| PIL: |
PIL_Imatinib Grindeks 100 mg tvrdé kapsuly_08.2023.pdf
|
| Safety feature | Yes |
| Data update: | 03.08.2023 |
